IKALTI Trademark

Trademark Overview


On Monday, October 15, 2018, a trademark application was filed for IKALTI with the United States Patent and Trademark Office. The USPTO has given the IKALTI trademark a serial number of 88155227. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 6, 2022. This trademark is owned by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED. The IKALTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonia, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhidrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable ...
ikalti

General Information


Serial Number88155227
Word MarkIKALTI
Filing DateMonday, October 15, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 6, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonia, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhidrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 25, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCOOLOCK, DUBLIN D17E400
IE

Party NameALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCOOLOCK, DUBLIN D17E400
IE

Trademark Events


Event DateEvent Description
Monday, June 6, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 6, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 25, 2021SOU EXTENSION 5 GRANTED
Monday, October 18, 2021SOU EXTENSION 5 FILED
Monday, October 25, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 18, 2021TEAS EXTENSION RECEIVED
Wednesday, March 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 15, 2021SOU EXTENSION 4 GRANTED
Monday, March 15, 2021SOU EXTENSION 4 FILED
Monday, March 15, 2021TEAS EXTENSION RECEIVED
Tuesday, October 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 2, 2020SOU EXTENSION 3 GRANTED
Friday, October 2, 2020SOU EXTENSION 3 FILED
Friday, October 2, 2020TEAS EXTENSION RECEIVED
Friday, April 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020SOU EXTENSION 2 GRANTED
Wednesday, April 8, 2020SOU EXTENSION 2 FILED
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Wednesday, October 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2019SOU EXTENSION 1 GRANTED
Monday, October 28, 2019SOU EXTENSION 1 FILED
Monday, October 28, 2019TEAS EXTENSION RECEIVED
Tuesday, April 30, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 24, 2019ASSIGNED TO EXAMINER
Thursday, October 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 18, 2018NEW APPLICATION ENTERED IN TRAM